JAÈøÆ»Áí¹çɱ¡¤Ç¤ÏÀ¸Ì¿¤Îº¤µ¤È¿Í´Ö°¦¤ò´ðÄ´¤Ë¡¢°å»Õ¡¦´Ç¸î»Õ¤È¤â¤ËÎϤò¹ç¤ï¤»¡¢É¤á¤ë¿Í¡¹¤ò¼é¤ê¡¢ÃÏ°è¤Î´ð´´É±¡¤È¤·¤Æ¤Î¼«³Ð¤ò»ý¤Á¡¢¾ï¤Ë¿·¤·¤¯¤è¤ê¹â¤¤Ãμ±¤Î½¬ÆÀ¤Èµ»½Ñ¤Î¸¦ïÓ¤ËÎå¤ß¤Þ¤¹¡£

JAÈøÆ»Áí¹çɱ¡

¥Û¡¼¥à ¡ä°åÎÅ´Ø·¸¼Ô¤ÎÊý¤Ø ¡äÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

Ãø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

ÅöÈøÆ»Áí¹çɱ¡¡¢¤ª¤è¤Ó³Æ°å»Õ¤Ë¤è¤Ã¤Æȯɽ¤µ¤ì¤¿Ãø½ñ¡¢³Ø²ñ¤Ç¤ÎȯɽÏÀʸ¤Ê¤É¤ò¸ø³«¤·¤Æ¤¤¤Þ¤¹¡£

ÈøÆ»Áí¹çɱ¡¡¦Ãø½ñ¡¦³Ø²ñ¡¦ÏÀʸ
 

[ ½Û´Ä´ïÆâ²Ê ] ¤Ë¤è¤ëÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

¡ÖÃø½ñ¡×¡Ö³Ø²ñ¡×¡ÖÏÀʸ¡×¤ÎʬÌî¤Ëʬ¤«¤ì¤Æ¤¤¤Þ¤¹¡£¤´´õ˾¤ÎʬÌî¤ò¥¯¥ê¥Ã¥¯¤¹¤ë¤È°ìÍ÷¤¬É½¼¨¤µ¤ì¤Þ¤¹¡£

¥Ç¡¼¥¿¹Ê¹þ
¥­¡¼¥ï¡¼¥É

!¹¹¿·Æü¡§2025/02/21

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë É·¿¿ÇÃǤ˶ìθ¤·¤¿¥¢¥ß¥í¥¤¥É¡¼¥·¥¹¤Î°ìÎã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¤33
¥Ú¡¼¥¸ÈÖ¹æ 13-16
Ãø¼Ô Éð»Ô°ìµ±
¶¦Ãø ½ÅΤÐÒÊ㡤ÌÚ²¼¹°´î¡¤Âç°æË®¿Ã¡¤ÂçÄͲíÌ顤¿¹Åç¿®¹Ô

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë µÞÀ­¿´¶Ú¹¼ºÉ¤ËÆÍȯÀ­¿©Æ»ÇËÎö¤ò¹çÊ»¤·¤¿¤¬Îɹ¥¤Êžµ¡¤òé¤Ã¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡75(9)
¥Ú¡¼¥¸ÈÖ¹æ 403-407
Ãø¼Ô Àж¶Ä¾¼ù
¶¦Ãø Ô¢Åıѻʡ¤»³º¬¡¡ºÌ¡¤±Ê°æÆ»ÌÀ¡¤¹áÀî±Ñ²ð¡¤¾®ÅÄ¡¡ÅС¤²ÃÆ£²íÌ顤ÀÄÌÚµÁϯ¡¤ÅÚ¼ê·Ä¸Þ¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ·ò¹¯¿ÇÃǤÎCT¤ò·Àµ¡¤Ëȯ¸«¤µ¤ì¤¿º¸Æâ·ÐÆ°Ì®ÇÙÆ°Ì®áñ¤Î°ìÎã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡32
¥Ú¡¼¥¸ÈÖ¹æ ¡ü11-14
Ãø¼Ô Àж¶Ä¾¼ù
¶¦Ãø ÂçÄͲíÌ顤Åìµ·¾ô¹§¡¤ÌÖ²¬Æ»¹§¡¤ÌÚ²¼¹°´î¡¤»³ÌÚ¡¡¼Â¡¤º´Æ£¹îÉÒ¡¤¿¹Åç¿®¹Ô¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë Impact of SGLT2 inhibitors on old age patients with heart failure and chronic kidney disease¡¥
»¨»ï¥¿¥¤¥È¥ë Int J Cardiol¡¥370
¥Ú¡¼¥¸ÈÖ¹æ 294-299
Ãø¼Ô Amioka M
¶¦Ãø Sanada R¡¤Matsumura H¡¤Kinoshita H¡¤Sairaku A¡¤Morishima N¡¤Nakano Y¡¥

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Does atrial
fibrillation ablation worsen preexisting anemia? Another anemia paradox in DOAC era
»¨»ï¥¿¥¤¥È¥ë Journal of Cardiology¡¥78¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 382¡Ý387
Ãø¼Ô Sairaku A
¶¦Ãø Morishima N¡¤Amioka M¡¤¡ÊMaeda J¡Ë¡¤¡ÊWatanabe Y¡Ë¡¤¡ÊNakano Y¡Ë

!¹¹¿·Æü¡§2022/05/24

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing
»¨»ï¥¿¥¤¥È¥ë Int J Cardiol¡¥301
¥Ú¡¼¥¸ÈÖ¹æ 142¡Ý146
Ãø¼Ô Kinoshita H
¶¦Ãø Sairaku A¡¤Morishima N¡¤¡ÊDohi Y¡Ë¡¤¡ÊSada Y¡Ë¡¤¡ÊHigashi A¡Ë¡¤¡ÊYamabe S¡Ë¡¤¡ÊKihara Y¡Ë

!¹¹¿·Æü¡§2022/05/24

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted direct oral anticoagulants: comparisons across 4 drugs.
»¨»ï¥¿¥¤¥È¥ë J Interv Card Electrophysiol¡¥doi: 10
¥Ú¡¼¥¸ÈÖ¹æ 1007/s10840-020-00851-6
Ãø¼Ô Sairaku A
¶¦Ãø Morishima N¡¤Matsumura H¡¤Amioka M¡¤Maeda J¡¤¡ÊWatanabe Y¡Ë¡¤¡ÊNakano Y¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë A mimic of tachycardia-bradycardia syndrome in a patient with long-standing persistent atrial fibrillation¡¥
»¨»ï¥¿¥¤¥È¥ë Clin Case Rep.¡¡7¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 661¡Ý664
Ãø¼Ô ¡Ê Akinori Sairaku¡Ë
¶¦Ãø ¡ÊTakeshi Matsumoto¡Ë¡¤Hiroki Kinoshita¡¤Hiroya Matsumura¡¤Naoto Oguri¡¤Nobuyuki Morishima

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Prognostic significance of oscillatory ventilation at rest in patients with advanced heart Failure undergoing cardiopulmonary exercise testing
»¨»ï¥¿¥¤¥È¥ë Int J Cardiol¡¡301
¥Ú¡¼¥¸ÈÖ¹æ 142-146
Ãø¼Ô Hiroki Kinoshita
¶¦Ãø Akinori Sairaku¡¤Nobuyuki Morishima¡¤¡ÊYoshihiro Dohi¡Ë¡¤¡ÊYoshiharu Sada¡Ë¡¤¡Ê Akifumi Higashi¡Ë¡¤¡ÊSayuri Yamabe¡Ë¡¤¡ÊYasuki Kihara¡Ë

!¹¹¿·Æü¡§2021/02/19

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯ 2020
¥¿¥¤¥È¥ë Intra-procedural anticoagulation and post-procedural hemoglobin fall in atrial fibrillation ablation with minimally interrupted directoral anticoagulants:comparisons across 4 drugs
»¨»ï̾ Journal of Interventional Cardiac Electrophysiology
Ãø¼Ô Akinori Sairaku¡¢Nobuyuki Morishima¡¢Hiroya Matsumura¡¢Michitaka Amioka¡¢Junji Maeda

!¹¹¿·Æü¡§2020/06/18

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Prognostic significance of oscillatory ventilation at rest in patients with advanced heart failure undergoing cardiopulmonary exercise testing.
»¨»ï¥¿¥¤¥È¥ë Int J Cardiol.
¥Ú¡¼¥¸ÈÖ¹æ 142-146
Ãø¼Ô Kinoshita H
¶¦Ãø Sairaku A, Morishima N, Dohi Y, Sada Y, Higashi A, Yamabe S, Kihara Y.

!¹¹¿·Æü¡§2020/06/17

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë A mimic of tachycardia-bradycardia syndrome in a patient with long-standing persistent atrial fibrillation.
»¨»ï¥¿¥¤¥È¥ë Clin Case Rep.¡¡7¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 661-664
Ãø¼Ô Sairaku A
¶¦Ãø Matsumoto T¡¤Kinoshita H¡¤Matsumura H¡¤Oguri N¡¤Morishima N

!¹¹¿·Æü¡§2020/06/17

¿ÇÎÅ²Ê ½Û´Ä´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure
»¨»ï¥¿¥¤¥È¥ë J Card Fail 24¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 520-524
Ãø¼Ô Okubo Y
¶¦Ãø Sairaku A¡¤Morishima N¡¤¡ÊOgi H¡Ë¡¤Matsumoto T¡¤Kinoshita H¡¤¡ÊKihara Y¡Ë

!¹¹¿·Æü¡§2020/06/17

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë A mimic of tachycardia-bradycardia syndrome in a patient with long-standing persistent atrial fibrillation.
»¨»ï¥¿¥¤¥È¥ë Clin Case Rep.
¥Ú¡¼¥¸ÈÖ¹æ 661-664
Ãø¼Ô Sairaku A
¶¦Ãø Matsumoto T, Kinoshita H, Matsumura H, Oguri N, Morishima N.

!¹¹¿·Æü¡§2020/06/16

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Increased Urinary Liver-Type Fatty Acid-Binding Protein Level Predicts Worsening Renal Function in Patients With Acute Heart Failure.
»¨»ï¥¿¥¤¥È¥ë J Card Fail.
¥Ú¡¼¥¸ÈÖ¹æ 520-524
Ãø¼Ô Okubo Y
¶¦Ãø Sairaku A, Morishima N, Ogi H, Matsumoto T, Kinoshita H, Kihara Y.

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¡¡V1¡Ý2 ͶƳ¤ÇST ¾å¾º¤òǧ¤á¤¿µÞÀ­²¼ÊÉ¿´¶Ú¹¼ºÉ¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 628¡Ý631
Ãø¼Ô ÀîºêÀµ·û
¶¦Ãø ¾åÅÄ·òÂÀϺ¡¤ËåÈø½ß¹°¡¤¡ÊÅÏî´µª¾½¡Ë¡¤ÈøÌÚ¡¡¹À¡¤¿¹Åç¿®¹Ô

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ÅDz¼·ì¤ò¼çÁʤËÍ象¤·¤¿Ê¢ÉôÂçÆ°Ì®áî½Ñ¸å¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66
¥Ú¡¼¥¸ÈÖ¹æ 266¡Ý269
Ãø¼Ô ¡ÊÅÏî´µª¾½¡Ë
¶¦Ãø ¾åÅÄ·òÂÀϺ¡¤ËåÈø½ß¹°¡¤ÈøÌÚ¡¡¹À¡¤¿¹Åç¿®¹Ô¡¤¡ÊÆó¿ÀÂç²ð¡Ë¡¤¡ÊßÀËÜÀµ¼ù¡Ë

!¹¹¿·Æü¡§2012/05/01

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë º¸Á°²¼¹Ô»ÞËýÀ­ÊĺÉÉÂÊѤËÂФ·Ãæ³Ö»Þ¤ò·Ðͳ¤¹¤ë¦Éû·ì¹ÔÏ©¤ò²ð¤·¤¿Æ±Â¦µÕ¹ÔÀ­¥¢¥×¥í¡¼¥Á¤Ë¤ÆºÆ³«Ä̤ËÀ®¸ù¤·¤¿°ìÎã
»¨»ï¥¿¥¤¥È¥ë CVIT Jpn Ed 4
¥Ú¡¼¥¸ÈÖ¹æ 48-52
Ãø½ñ ÅÏî´µª¾½
¶¦Ãø ¡Ê±ö½ÐÀëͺ¡Ë¡¤¡ÊÀµ²¬²Â»Ò¡Ë¡¤¡Ê¼²¬Íµ»Ê¡Ë¡¤¡ÊË­Ê¡¡¡¼é¡Ë¡¤¡Ê²­ËÜÃÒÏ¡ˡ¤¡ÊÂçÄͲíÌé¡Ë¡¤¡Ê°ÙÀ¶ÇîÆ»¡Ë¡¤¡Ê»°¸Í¿¹»ù¡Ë¡¤¡ÊÀîÀ¥¶¦¼£¡Ë¡¤¡Ê¹áÀîͺ»°¡Ë¡¤ËåÈø½ß¹°¡¤¡ÊÎÓ¡¡¹¯É§¡Ë

!¹¹¿·Æü¡§2011/05/01

¿ÇÎÅ²Ê ½Û´Ä´ï²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë A case of adult ductus arteriosus with congestive heart failure and severe mitral regurgitation.
»¨»ï¥¿¥¤¥È¥ë Cardiovasc Interv and Ther 26
¥Ú¡¼¥¸ÈÖ¹æ 278-280
Ãø½ñ Watanabe N
¶¦Ãø ¡ÊToyofuku M¡Ë¡¤¡ÊHayashi Y¡Ë¡¥
µá¿Í¾ðÊó¤Î¤ªÃΤ餻 Åö±¡¤Ï(ºâ)ÆüËÜ°åÎÅɾ²Áµ¡¹½¤Ë¤è¤ëǧÄê¤ò¼õ¤±¤Æ¤¤¤Þ¤¹¡£

JAÈøÆ»Áí¹çɱ¡Î×¾²²Ê¤Î¥Õ¥§¥¤¥¹¥Ö¥Ã¥¯ Î×¾²²Ê

JAÈøÆ»Áí¹çɱ¡Î×¾²¸¦½¤²Ê¤Î¥Õ¥§¥¤¥¹¥Ö¥Ã¥¯ Î×¾²¸¦½¤²Ê

JAÈøÆ»Áí¹çɱ¡ »Ô̱¸ø³«¹ÖºÂ »Ô̱¤Î¤¿¤á¤Î¤¬¤óºÇÁ°Àþ

JAÈøÆ»Áí¹çɱ¡ ÇÛ¿®Æ°²è°ìÍ÷

 
¥Ú¡¼¥¸ÀèƬ¤ØÌá¤ë